On July 30, the U.S. Geological Survey announced approximately $4 million in awards to Caltech, UC Berkeley, the University of Washington and the University of Oregon, for the expansion and improvement of the ShakeAlert system.
As part of a program to foster innovative biomedical research projects, an anonymous donor has pledged $3 million each to Caltech and City of Hope to strengthen scientific collaborations between the two leading research institutions.
As part of a National Institutes of Health (NIH) initiative to stimulate highly innovative research and support promising new scientific investigators, two scientists from Caltech were named among the 2010 class of the NIH Director's New Innovator Award recipients.
The National Institutes of Health has awarded $11.5 million to a consortium of research institutions led by the California Institute of Technology for the creation of a center for the study of membrane-protein structures.
Caltech has established the Terrestrial Hazard Observation and Reporting Center (THOR), funded by $6.7 million from Foster and Coco Stanback, and $3.35 million from the Gordon and Betty Moore matching program.
Caltech is opening the new Warren and Katharine Schlinger Laboratory for Chemistry and Chemical Engineering. The state-of-the-art, sustainable Schlinger Laboratory will provide a custom-designed, adaptable facility for a number of Caltech's chemists and chemical engineers, and will house synthetic chemistry and chemical engineering, enabling new research in catalysis, materials, and the atmosphere.
Research in genomic sciences, astronomy, seismology, and neuroeconomics are some of the many projects being funded at the California Institute of Technology (Caltech) by the American Recovery and Reinvestment Act (ARRA).
A gift of $3.9 million from the estate of Edward and Ruth Hughes to the California Institute of Technology (Caltech) wll support graduate research fellowships in the Division of Chemistry and Chemical Engineering (CCE).
Caltech and UCLA have announced the establishment of the Joint Center for Translational Medicine (JCTM), which will advance experimental research into clinical applications, including the diagnosis and therapy of diseases such as cancer.